The Ethics & Public Policy (EPP) component of this Center is based in the University of Minnesota’s Consortium on Law and Values in Health, Environment & the Life Sciences; ATP-Bio has joined the Consortium to link to centers doing related work. EPP will work with ATP-Bio researchers and an Ethics & Public Policy Panel (EP3) composed of multidisciplinary national experts in ethics and policy. EPP will build an integrated and interdisciplinary program of ethics & policy analysis to support research and development of ATP-Bio’s technology for public benefit, including efforts to:
1. Analyze ethics & policy challenges raised by ATP-Bio research & key applications
Identify ethical, legal & societal issues (ELSI) raised by ATP-Bio research & applications
Collaborate within and outside ATP-Bio to analyze ELSI issues in ATP-Bio
2. Advance ethical development & deployment of ATP-Bio technologies for societal benefit
Conduct ELSI analysis of ATP-Bio technologies anticipating development & deployment
Develop and publish ethics & policy analyses focused on ATP-Bio technologies
Offer events & online portal of ethics & policy resources
Collaborate on research & publication
3. Expose ATP-Bio investigators & trainees to EPP questions & methods
4. Collaborate with NSF & ERCs in Stakeholder Engagement & Impact Collaborative (SEIC)
Collaborate across the Gen-4 ERCs in the NSF Stakeholder Engagement & Impact Collaborative (SEIC)
5. Conduct groundbreaking NetEthics project funded by NSF
Analyze challenges facing complex engineering networks like ERCs
Develop tools to advance ethics & responsible conduct of research (RCR) in engineering networks
Susan Wolf, JD (UMN)
Ethics and Public Policy Lead
Timothy Pruett, MD (UMN)
Ethics and Public Policy Co-Lead